Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kommalapati, A., Tella, S.H., and Goyal, G. (2018). Contemporary Management of Localized Resectable Pancreatic Cancer. Cancers (Basel), 10.
Suker, 2016, FOLFIRINOX for locally advanced pancreatic cancer: A systematic review and patient-level meta-analysis, Lancet Oncol., 17, 801, 10.1016/S1470-2045(16)00172-8
Peinado, 2017, Pre-metastatic niches: Organ-specific homes for metastases, Nat. Rev. Cancer, 17, 302, 10.1038/nrc.2017.6
Aiello, 2015, Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver, Nat. Cell Biol., 17, 816, 10.1038/ncb3169
Liu, 2016, Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils, Cancer Cell, 30, 243, 10.1016/j.ccell.2016.06.021
Liu, 2016, Characteristics and Significance of the Pre-metastatic Niche, Cancer Cell, 30, 668, 10.1016/j.ccell.2016.09.011
Thery, 2002, Exosomes: Composition, biogenesis and function, Nat. Rev. Immunol., 2, 569, 10.1038/nri855
Siljander, 2015, Biological properties of extracellular vesicles and their physiological functions, J. Extracell. Vesicles, 4, 27066, 10.3402/jev.v4.27066
Luan, 2017, Engineering exosomes as refined biological nanoplatforms for drug delivery, Acta Pharmacol. Sin., 38, 754, 10.1038/aps.2017.12
S, 2013, Extracellular vesicles: Biology and emerging therapeutic opportunities, Nat. Rev. Drug Discov., 12, 347, 10.1038/nrd3978
Kamerkar, 2017, Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer, Nature, 546, 498, 10.1038/nature22341
Jang, 2013, Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors, ACS Nano, 7, 7698, 10.1021/nn402232g
Saari, 2015, Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells, J. Control. Release Off. J. Control. Release Soc., 220, 727, 10.1016/j.jconrel.2015.09.031
Garofalo, 2019, Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice, J. Control. Release Off. J. Control. Release Soc., 294, 165, 10.1016/j.jconrel.2018.12.022
Hoshino, 2015, Tumour exosome integrins determine organotropic metastasis, Nature, 527, 329, 10.1038/nature15756
Gurlevik, 2016, Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells, Gastroenterology, 151, 338, 10.1053/j.gastro.2016.05.004
Ames, E., Canter, R.J., Grossenbacher, S.K., Mac, S., Chen, M., Smith, R.C., Hagino, T., Perez-Cunningham, J., Sckisel, G.D., and Urayama, S. (2015). NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. J. Immunol.
Mamessier, 2011, Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity, J. Clin. Investig., 121, 3609, 10.1172/JCI45816
Platonova, 2011, Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma, Cancer Res., 71, 5412, 10.1158/0008-5472.CAN-10-4179
Sun, 2017, High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer, Oncoimmunology, 6, e1264562, 10.1080/2162402X.2016.1264562
Cong, 2018, Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression, Cell Metab., 28, 243, 10.1016/j.cmet.2018.06.021
Jewett, 2011, Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cells, J. Cancer, 2, 443, 10.7150/jca.2.443
Li, 2012, Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO, Cancer Lett., 318, 154, 10.1016/j.canlet.2011.12.020
Sheppard, 2018, The Paradoxical Role of NKG2D in Cancer Immunity, Front. Immunol., 9, 1808, 10.3389/fimmu.2018.01808
Alter, 2004, CD107a as a functional marker for the identification of natural killer cell activity, J. Immunol. Methods, 294, 15, 10.1016/j.jim.2004.08.008
Wang, 2012, Natural killer cell-produced IFN-gamma and TNF-alpha induce target cell cytolysis through up-regulation of ICAM-1, J. Leukoc. Biol., 91, 299, 10.1189/jlb.0611308
O’Brien, K.L., and Finlay, D.K. (2019). Immunometabolism and natural killer cell responses. Nat. Rev. Immunol.
Viel, 2016, TGF-beta inhibits the activation and functions of NK cells by repressing the mTOR pathway, Sci. Signal., 9, ra19, 10.1126/scisignal.aad1884
Rouce, 2016, The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia, Leukemia, 30, 800, 10.1038/leu.2015.327
Peinado, 2012, Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET, Nat. Med., 18, 883, 10.1038/nm.2753
Tkach, 2016, Communication by Extracellular Vesicles: Where We Are and Where We Need to Go, Cell, 164, 1226, 10.1016/j.cell.2016.01.043
Yu, 2017, Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation, Oncotarget, 8, 63461, 10.18632/oncotarget.18831
Hamidi, 2018, Every step of the way: Integrins in cancer progression and metastasis, Nat. Rev. Cancer, 18, 533, 10.1038/s41568-018-0038-z
Gasser, 2005, The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor, Nature, 436, 1186, 10.1038/nature03884
Bauer, 1999, Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA, Science, 285, 727, 10.1126/science.285.5428.727
Gardiner, 2017, What Fuels Natural Killers? Metabolism and NK Cell Responses, Front. Immunol., 8, 367, 10.3389/fimmu.2017.00367
Berchem, 2016, Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-beta and miR23a transfer, Oncoimmunology, 5, e1062968, 10.1080/2162402X.2015.1062968
Chen, 2018, Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response, Nature, 560, 382, 10.1038/s41586-018-0392-8
Xia, 2017, Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway, Oncotarget, 8, 37783, 10.18632/oncotarget.16354
Kim, M.P., Fleming, J.B., Wang, H., Abbruzzese, J.L., Choi, W., Kopetz, S., McConkey, D.J., Evans, D.B., and Gallick, G.E. (2011). ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS ONE, 6.
Shiozawa, 2013, Cancer stem cells and their role in metastasis, Pharmacol. Ther., 138, 285, 10.1016/j.pharmthera.2013.01.014
Lee, 2004, Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients, J. Immunol., 172, 7335, 10.4049/jimmunol.172.12.7335
Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-β family signalling, Nature, 425, 577, 10.1038/nature02006
Halder, 2005, A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers, Neoplasia, 7, 509, 10.1593/neo.04640
Yadav, 2018, Liquid biopsy in pancreatic cancer: The beginning of a new era, Oncotarget, 9, 26900, 10.18632/oncotarget.24809
Theodoraki, 2018, Clinical Significance of PD-L1(+) Exosomes in Plasma of Head and Neck Cancer Patients, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res., 24, 896, 10.1158/1078-0432.CCR-17-2664
Gonzalez, 2017, Control of Metastasis by NK Cells, Cancer Cell, 32, 135, 10.1016/j.ccell.2017.06.009
Stanietsky, 2009, The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity, Proc. Natl. Acad. Sci. USA, 106, 17858, 10.1073/pnas.0903474106
Zhang, 2018, Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity, Nat. Immunol., 19, 723, 10.1038/s41590-018-0132-0
Borghaei, 2015, Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer, N. Engl. J. Med., 373, 1627, 10.1056/NEJMoa1507643
Brahmer, 2015, Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer, N. Engl. J. Med., 373, 123, 10.1056/NEJMoa1504627
Hamid, 2013, Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma, N. Engl. J. Med., 369, 134, 10.1056/NEJMoa1305133
Morrison, 2018, Immunotherapy and Prevention of Pancreatic Cancer, Trends Cancer, 4, 418, 10.1016/j.trecan.2018.04.001
Olson, 2018, Mouse Models for Cancer Immunotherapy Research, Cancer Discov., 8, 1358, 10.1158/2159-8290.CD-18-0044